News Daily News High Risk of Major Bleeding Observed in Danish A-fib Population on Triple, Dual Antithrombotic Therapy Yael L. Maxwell December 13, 2018
News Daily News Quality of Anticoagulation Therapy Lower in Black Patients With A-fib Todd Neale December 03, 2018
News Daily News Patients With A-fib and Cancer May Benefit From Visiting With a Cardiologist Early On Todd Neale October 10, 2018
News Daily News DOACs Safe, Effective in A-fib Patients With Preexisting LAA Thrombus Caitlin E. Cox October 04, 2018
News Daily News Stay Away From Warfarin-Based Triple Therapy in Patients With A-fib and CAD, Study Affirms Todd Neale October 03, 2018
News Conference News ESC 2018 New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All Michael O'Riordan August 29, 2018
News Daily News Edoxaban Looks Good for Asians With A-fib in Real-world Analysis Todd Neale August 14, 2018
News Daily News Intracranial Hemorrhage Outside of A-fib: Different NOACs, Different Risks Todd Neale August 13, 2018
News Daily News Ischemic Stroke Risk Scoring May Not Be Accurate for Patients With Atrial Flutter L.A. McKeown August 03, 2018
News Daily News New Consensus Statement: NOAC and Clopidogrel for Most A-fib Patients Treated With PCI Michael O'Riordan July 31, 2018
News Daily News Asian Patients With A-fib Don’t Gain Anything From Low-Dose Rivaroxaban Todd Neale July 24, 2018
News Daily News NOACs Particularly Beneficial for Women With A-fib, Study Suggests Todd Neale July 11, 2018
News Daily News Bleeding Risk Increased With NSAID Use in Anticoagulated A-fib Patients: RE-LY Analysis L.A. McKeown July 10, 2018
News Daily News Real-world Analysis Suggests Apixaban Is Safest of the NOACs, Even for Patients With A-fib L.A. McKeown July 06, 2018
News Conference News HRS 2018 Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk Todd Neale May 14, 2018
News Conference News HRS 2018 NOACs Perform Worse Than Warfarin in Real-World Study, Especially When Adherence Is Low Todd Neale May 11, 2018
News Daily News Andexanet Alfa, First Reversal Agent for Factor Xa Inhibitors, Finally Gains FDA Approval Todd Neale May 04, 2018
News Daily News Less Bleeding, Similar Outcomes With Dual vs Triple Therapy After PCI in Patients With A-fib Todd Neale April 24, 2018